Sotio a.s.
Overview
Sotio a.s. is a biotech company focused on developing innovative therapies for cancer patients. As a subsidiary of PPF Group, it is dedicated to advancing clinical trials to create new treatment options.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Sotio a.s. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.